SEC Form 4 · accession 0000939767-19-000027
EXELIXIS, INC. · EXEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gisela Schwab
Officer — Pres, Prod Dev & Med Aff & CMO
Period of report
Feb 14, 2019
Accepted (ET)
Feb 15, 2019 · 8:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000939767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 14, 2019 | M | 100,000 | $5.56 | A | 416,513 | D | |
| Common StockF2 | Feb 14, 2019 | S | 100,000 | $21.66 | D | 316,513 | D | |
| Common Stock | Feb 15, 2019 | M | 23,000 | $5.56 | A | 339,513 | D | |
| Common Stock | Feb 15, 2019 | S | 23,000 | $22.20 | D | 316,513 | D | |
| Common StockF3 | holding | — | — | — | 14,644 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F4 | $5.56 | Feb 14, 2019 | M | 100,000 | D | Sep 21, 2013 | Sep 20, 2019 | Common Stock | 100,000 | 23,000 | D |
| Option (right to buy)F4 | $5.56 | Feb 15, 2019 | M | 23,000 | D | Sep 21, 2013 | Sep 20, 2019 | Common Stock | 23,000 | 0 | D |
Explanation of responses
- F1Includes 66,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.39 to $22.02 Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- F3Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 13, 2019.
- F4The option, representing the right to purchase a total of 123,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 21, 2016.